Levels Secures $7M Series A Extension Funding to Solve Metabolic Health Crisis
Levels, a software company that provides real-time feedback on how food affects your health, announced today $7 million in series A extension funding. The extension follows a $38 million Series A round in April 2022, and strengthens ties with existing and new individual investors and funds like TriplePoint Capital. Levels helps people see how food affects their health via a mobile application that leverages data from biosensors and other sources, such as Apple Health.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005295/en/
Levels helps you see how food affects your health. (Photo: Business Wire)
To date, Levels has raised more than $55 million to solve the metabolic health crisis. Existing investors include a16z, Trust Ventures, and Shrug Capital as well as notable founders and the Levels member community.
With the close of this funding extension, Levels continues to advance its mission, providing members with the tools and education needed to improve their health. The additional capital enables the company to expand access to its holistic suite of member services including: the Levels app providing real-time feedback and guidance to help members improve their nutrition, exercise, sleep, and more; an engaged community; educational materials and expert insights including a podcast and blog; as well as access to continuous glucose monitors (CGMs) and on-demand blood testing to track metabolic markers.
Levels' Approach to Solving the Metabolic Health Crisis
In the United States, 8 of the 10 leading causes of death are related to high blood sugar. Of the 88 million people with prediabetes, 90% are unaware of their condition. Levels' mission is to solve the metabolic health crisis by increasing accessibility to biomarkers, like real-time glucose, which are known to affect our health and risk of disease. Within the next five years, our goal is to shift the focus from healthcare to prevention, create transparency in the food industry, and provide individual empowerment through personal data.
In addition, Levels is conducting the largest ever study of its kind in collaboration with top researchers from around the world to increase understanding of glucose patterns among a wide variety of people (age, gender, and race) and advance the science about how lifestyle choices can affect these patterns.
ABOUT LEVELS HEALTH
Levels helps you see how food affects your health, empowering you with the tools needed to achieve health goals and improve healthspan. By leveraging data shared by members from biosensors like continuous glucose monitors (CGM), Levels provides real-time feedback on how diet and lifestyle choices impact your metabolic health. Our Members are using personalized data to discover their optimal diet, control their weight, and reduce long-term health risk.
Casey Means, MD (Stanford MD), Josh Clemente (SpaceX, Hyperloop), Sam Corcos (CarDash, YC), David Flinner (Google), and Andrew Conner (Google) founded Levels to solve the metabolic health crisis.
The Levels Advisory Board includes key thought leaders, clinicians and researchers in metabolic health, including Dr. Rangan Chatterjee, David Sinclair, PhD; Dr. Robert Lustig; Dr. Sara Gottfried; Ben Bikman, PhD; Dom D'Agostino, PhD; Dr. Mark Hyman; Dr. Molly Maloof; Dr. David Perlmutter; Dr. Terry Wahls; and Dr. Gerald Shulman.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005295/en/